During the past decade, SUNY at Stony Brook / Div of Infectious Disease conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "SUNY at Stony Brook / Div of Infectious Disease" are "HIV Infections" (7 trials). Many other conditions were trialed in "SUNY at Stony Brook / Div of Infectious Disease" in a lesser frequency.

Most popular intervention types in "SUNY at Stony Brook / Div of Infectious Disease" are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "Lamivudine" (5 trials), "Stavudine" (5 trials), "Indinavir sulfate" (4 trials), "Lopinavir/Ritonavir" (2 trials) and "Nelfinavir mesylate" (2 trials). Other intervention names were less common.

The vast majority of trials in "SUNY at Stony Brook / Div of Infectious Disease" are 7 trials for "All" genders.

Currently, there are NaN active trials in "SUNY at Stony Brook / Div of Infectious Disease". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in SUNY at Stony Brook / Div of Infectious Disease, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in SUNY at Stony Brook / Div of Infectious Disease, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".